CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...

Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Dr ...

Demonstrators accused the company's insurance arm of a "systemic practice of refusing to approve care through prior authorization denials or pay for care through claim denials," according to protest ...

A scientific statement has been issued by the American Heart Association regarding the management and diagnosis of Kawasaki disease.

Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...

Real-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...

Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...